April 6, 2023 06:13 AM EDTUpdated 06:25 AM
Peer Review

Af­ter decades in Big Phar­ma, Kel­ly Page heads to 'growth stage'; Al­lied with No­var­tis, Bi­cy­cle se­lects de­vel­op­ment chief

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Nicole DeFeudis

Editor

Fol­low­ing a decades-long ca­reer in Big Phar­ma, Kel­ly Page want­ed to use her re­search and com­mer­cial ex­pe­ri­ence to help a small com­pa­ny grow.

Last Tues­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Ky­owa Kirin ac­quires ex-US rights to Ku­ra’s leukemia treat­ment for $330M up­front

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times